AXSOME THERAPEUTICS INC (AXSM:NASDAQ)
$220.78 9.665 (4.5781%)
Analysed AXSOME THERAPEUTICS INC (AXSM:NASDAQ) News Sources
Axsome Therapeutics shares gain 2% as strong sales growth offsets Q2 miss
10-08-2026
advfn.com
AXSM Stock Advances On CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030
10-08-2026
stocktwits.com
Does Axsome Therapeutics (AXSM) Look Fairly Valued At This Price?
11-08-2026
yahoo.com
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
23-08-2026
fool.com
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
29-08-2026
fool.com
Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation
31-08-2026
yahoo.com
Axsome (AXSM) Down 3.7% Since Last Earnings Report: Can It Rebound?
09-09-2026
yahoo.com
Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
10-09-2026
fool.com
Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
11-09-2026
fool.com
AXSM Jumps 6% As Mizuho Calls Auvelity’s Alzheimer’s Launch A ‘Strong Start’
11-09-2026
stocktwits.com
What is the current price of AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The current price of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is $220.78.
AXSOME THERAPEUTICS INC (AXSM:NASDAQ) absolute price change since previous trading day?
The absolute price change of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) since the previous trading day is $9.665.
AXSOME THERAPEUTICS INC (AXSM:NASDAQ) percentage price change since previous trading day?
The percentage price change of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) since the previous trading day is 4.5781%.
What is the most recent average sentiment score for AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The most recent average sentiment score for AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The most recent sentiment for AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is .
SEC-8K** Filing Available For AXSOME THERAPEUTICS INC (AXSM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.